Insider Transactions Reported by 7 Insiders of MAINZ BIOMED N.V.

Symbol
MYNZ on Nasdaq
Location
Mainz, Germany

Insiders trading volume in the past year

MAINZ BIOMED N.V. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Kevin Michael Donahue 10%+ Owner $1,034,350 +$1,034,350 17 Oct 2025
Guido Baechler Chief Executive Officer, Director $738,170 13 Feb 2026
William J. Caragol Chief Financial Officer $448,836 13 Feb 2026
Heinrich Dreismann Director $78,934 13 Feb 2026
Gregory J. Tibbitts Director $68,167 13 Feb 2026
Hans Hekland Director $54,900 01 Jan 2026
David E. Lazar Director $0 13 Feb 2026

Recent Insider Transactions by Companies or Individuals for MAINZ BIOMED N.V.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
David E. Lazar MYNZ Series C Preferred Shares Award 1,000,000 1,000,000 13 Feb 2026 Direct
David E. Lazar MYNZ Series B Preferred Shares Award 1,000,000 1,000,000 13 Feb 2026 Direct
David E. Lazar MYNZ Series A Preferred Shares Award 1,000,000 1,000,000 13 Feb 2026 Direct
William J. Caragol MYNZ Ordinary Shares Award 372.3% 290,000 367,899 13 Feb 2026 Direct
Heinrich Dreismann MYNZ Ordinary Shares Award 228.4% 45,000 64,700 13 Feb 2026 Direct
Gregory J. Tibbitts MYNZ Ordinary Shares Award 413.8% 45,000 55,875 13 Feb 2026 Direct
Guido Baechler MYNZ Ordinary Shares Award 266.6% 440,000 605,058 13 Feb 2026 Direct
Kevin Michael Donahue MYNZ Common Stock Purchase $1,034,350 $1.51 685,000 685,000 17 Oct 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.